On January 11 th, 2024, Spectral announced that it began enrollment of its pivotal study to validate DeepView for burn injuries. The study enrolled and analyzed data from 164 patients, consisting ...

DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) ("Spectral AI” or the "Company”), developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation ...

The DeepView System demonstrated a statistically significant improvement in identifying non-healing tissue compared to burn physician. Spectral AI plans to submit these results to the FDA as part ...

Spectral AI’s Deepview System has outperformed burn physicians in identifying non-healing tissue, the company said Monday. Deepview achieved 86.6% sensitivity when identifying non-healing tissue at an ...

DeepView ® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performance Spectral AI ...

Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn ...

DeepView ® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performance Spectral AI plans ...

DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView ® System, that uses multi-spectral imaging and ...

DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView ® System, that uses multi-spectral imaging and AI algorithms ...

There are key skills to improv comedy. You have to fly by the seat of your pants, react in the moment, stay present, and remain in character, no matter what scenario is thrown at you. Those same ...